GENE ONLINE|News &
Opinion
Blog

Donanemab
GeneOnline’s Weekly News Highlights: July 17-21
2023-07-24
FDA Grants Breakthrough Status to Two Experimental Alzheimer’s Drugs While Pushback Over Aduhelm’s Approval Still Rages On
2021-06-25
Lilly’s Positive Data for Alzheimer’s Drug Bodes Well for Candidates Rooted in Amyloid Hypothesis
2021-03-14
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
LATEST
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
Partnership to Manufacture Antibiotic to Combat Antimicrobial Resistance
2023-09-25
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Largest Biotech Event of Thailand Takes Center Stage
2023-09-22
BIOHK2023: A Place Where Biotechnology Meets Financial Economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top